Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2020
ESGO contribution to the WHO initiative on elimination of cervical cancerMurat Gultekin, Philippe Morice, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 29, 2021
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?Nicole Concin, Xavier Matias-Guiu, Carien L Creutzberg, et al.
The Lancet. Oncology|October 30, 2025
It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer - Authors' replyTjalling Bosse, Remi Nout, Xavier Matias-Guiu, et al.
Cancers|October 16, 2024
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?Arina Onoprienko, Thomas Bartl, Christoph Grimm, et al.
Cancer Epidemiology|January 9, 2013
Lifestyle-related biomarkers and endometrial cancer survival: elevated gamma-glutamyltransferase as an important risk factorMichael Edlinger, Nicole Concin, Hans Concin, et al.
Wiener Klinische Wochenschrift|August 30, 2008
Genetic analyses in a variant of Mayer-Rokitansky-Kuster-Hauser syndrome (MURCS association)Gerda Hofstetter, Nicole Concin, Christian Marth, et al.
Plos One|January 7, 2017
The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective StudyVeronika Seebacher, Alexander Reinthaller, Heinz Koelbl, et al.
BMC Cancer|October 26, 2017
The relative risk of second primary cancers in Austria's western states: a retrospective cohort studyOliver Preyer, Nicole Concin, Andreas Obermair, et al.
Obstetrics and Gynecology|November 4, 2008
Influence of the time interval between hysteroscopy, dilation and curettage, and hysterectomy on survival in patients with endometrial cancerLukas Hefler, Heinz Leipold, Stefan Hinterberger, et al.
Genes|July 2, 2021
BARD1 Autoantibody Blood Test for Early Detection of Ovarian CancerMaxim Pilyugin, Magdalena Ratajska, Maciej Stukan, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2020
ESGO contribution to the WHO initiative on elimination of cervical cancerMurat Gultekin, Philippe Morice, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 29, 2021
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?Nicole Concin, Xavier Matias-Guiu, Carien L Creutzberg, et al.
The Lancet. Oncology|October 30, 2025
It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer - Authors' replyTjalling Bosse, Remi Nout, Xavier Matias-Guiu, et al.
Cancers|October 16, 2024
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?Arina Onoprienko, Thomas Bartl, Christoph Grimm, et al.
Cancer Epidemiology|January 9, 2013
Lifestyle-related biomarkers and endometrial cancer survival: elevated gamma-glutamyltransferase as an important risk factorMichael Edlinger, Nicole Concin, Hans Concin, et al.
Wiener Klinische Wochenschrift|August 30, 2008
Genetic analyses in a variant of Mayer-Rokitansky-Kuster-Hauser syndrome (MURCS association)Gerda Hofstetter, Nicole Concin, Christian Marth, et al.
Plos One|January 7, 2017
The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective StudyVeronika Seebacher, Alexander Reinthaller, Heinz Koelbl, et al.
BMC Cancer|October 26, 2017
The relative risk of second primary cancers in Austria's western states: a retrospective cohort studyOliver Preyer, Nicole Concin, Andreas Obermair, et al.
Obstetrics and Gynecology|November 4, 2008
Influence of the time interval between hysteroscopy, dilation and curettage, and hysterectomy on survival in patients with endometrial cancerLukas Hefler, Heinz Leipold, Stefan Hinterberger, et al.
Genes|July 2, 2021
BARD1 Autoantibody Blood Test for Early Detection of Ovarian CancerMaxim Pilyugin, Magdalena Ratajska, Maciej Stukan, et al.
Pageof 14